# | Title | Journal | Year | Citations |
---|
1 | PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer | Breast Care | 2016 | 20,872 |
2 | Trastuzumab-Induced Hepatotoxicity: A Case Report | Breast Care | 2013 | 2,975 |
3 | A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition | Breast Care | 2013 | 280 |
4 | Comparison of Ductoscopy, Galactography, and Imaging Modalities for the Evaluation of Intraductal Lesions: A Critical Review | Breast Care | 2013 | 274 |
5 | Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients | Breast Care | 2016 | 248 |
6 | St. Gallen 2011: Summary of the Consensus Discussion | Breast Care | 2011 | 194 |
7 | Breast Cancer Care in India: The Current Scenario and the Challenges for the Future | Breast Care | 2008 | 191 |
8 | The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer | Breast Care | 2018 | 135 |
9 | St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment | Breast Care | 2019 | 131 |
10 | Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries | Breast Care | 2019 | 125 |
11 | St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion | Breast Care | 2013 | 123 |
12 | Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications | Breast Care | 2013 | 117 |
13 | St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment | Breast Care | 2017 | 109 |
14 | Advantages and Disadvantages of Mammography Screening | Breast Care | 2011 | 108 |
15 | 13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013) | Breast Care | 2013 | 98 |
16 | Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge | Breast Care | 2018 | 97 |
17 | Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer | Breast Care | 2016 | 92 |
18 | St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer | Breast Care | 2021 | 90 |
19 | AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016 | Breast Care | 2016 | 88 |
20 | HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer | Breast Care | 2013 | 85 |
21 | Biological Subtypes of Triple-Negative Breast Cancer | Breast Care | 2017 | 85 |
22 | St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion | Breast Care | 2015 | 82 |
23 | Current Status and Future Projections of Breast Cancer in Asia | Breast Care | 2015 | 77 |
24 | AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019 | Breast Care | 2019 | 72 |
25 | AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013 | Breast Care | 2013 | 68 |
26 | Online Survey of Patients with Breast Cancer on Complementary and Alternative Medicine | Breast Care | 2014 | 68 |
27 | Local Treatment of the Axilla in Early Breast Cancer: Concepts from the National Surgical Adjuvant Breast and Bowel Project B-04 to the Planned Intergroup Sentinel Mamma Trial | Breast Care | 2014 | 68 |
28 | Differentiation between Phyllodes Tumors and Fibroadenomas Based on Mammographic Sonographic and MRI Features | Breast Care | 2016 | 68 |
29 | The German SUCCESS C Study – The First European Lifestyle Study on Breast Cancer | Breast Care | 2010 | 65 |
30 | Oligometastatic Breast Cancer: A Shift from Palliative to Potentially Curative Treatment? | Breast Care | 2014 | 65 |
31 | Male Breast Cancer | Breast Care | 2008 | 61 |
32 | Targeted Therapies in Triple-Negative Breast Cancer | Breast Care | 2015 | 60 |
33 | Germline Mutations in Triple-Negative Breast Cancer | Breast Care | 2017 | 59 |
34 | Metabolic Syndrome and Breast Cancer: Is There a Link? | Breast Care | 2014 | 57 |
35 | Tumor-Associated Antigens in Breast Cancer | Breast Care | 2012 | 56 |
36 | Polycyclic Aromatic Hydrocarbons and Breast Cancer: A Review of the Literature | Breast Care | 2015 | 55 |
37 | The Course of Anxiety and Depression in Patients with Breast Cancer and Gynaecological Cancer | Breast Care | 2008 | 54 |
38 | Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response | Breast Care | 2017 | 53 |
39 | Evaluation of Social Support, Quality of Life, and Body Image in Women with Breast Cancer | Breast Care | 2016 | 52 |
40 | Physical Activity, Exercise and Breast Cancer - What Is the Evidence for Rehabilitation, Aftercare, and Survival A Review | Breast Care | 2018 | 52 |
41 | Influence of Lifestyle Factors on Breast Cancer Risk | Breast Care | 2014 | 51 |
42 | AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 | Breast Care | 2021 | 51 |
43 | Radionuclide Therapy of Bone Metastases | Breast Care | 2012 | 50 |
44 | Role of Breast Ultrasound for the Detection and Differentiation of Breast Lesions | Breast Care | 2010 | 49 |
45 | Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries | Breast Care | 2011 | 49 |
46 | Subclinical Breast Cancer: Minimally Invasive Approaches. Our Experience with Percutaneous Radiofrequency Ablation vs. Cryotherapy | Breast Care | 2013 | 48 |
47 | Management of Breast Cancer Patients with Chemotherapy-Induced Neutropenia or Febrile Neutropenia | Breast Care | 2014 | 48 |
48 | Adaptive Coping and Spirituality as a Resource in Cancer Patients | Breast Care | 2007 | 47 |
49 | Fungating Wounds – Multidimensional Challenge in Palliative Care | Breast Care | 2011 | 47 |
50 | Breast Cancer Risks and Risk Prediction Models | Breast Care | 2015 | 47 |